|
1
|
Shanb AA and Youssef EF: The impact of
adding weight-bearing exercise versus nonweight bearing programs to
the medical treatment of elderly patients with osteoporosis. J
Family Community Med. 21:176–181. 2014.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Lin J, Zhu J, Wang Y, Zhang N, Gober HJ,
Qiu X, Li D and Wang L: Chinese single herbs and active ingredients
for postmenopausal osteoporosis: From preclinical evidence to
action mechanism. Biosci Trends. 11:496–506. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hamdy NA: Targeting the RANK/RANKL/OPG
signaling pathway: A novel approach in the management of
osteoporosis. Curr Opin Investig Drugs. 8:299–303. 2007.PubMed/NCBI
|
|
4
|
Li X, Jie Q, Zhang H, Zhao Y, Lin Y, Du J,
Shi J, Wang L, Guo K, Li Y, et al: Disturbed MEK/ERK signaling
increases osteoclast activity via the Hedgehog-Gli pathway in
postmenopausal osteoporosis. Prog Biophys Mol Biol. 122:101–111.
2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Granéli C, Karlsson C, Brisby H, Lindahl A
and Thomsen P: The effects of PPAR-γ inhibition on gene expression
and the progression of induced osteogenic differentiation of human
mesenchymal stem cells. Connect Tissue Res. 55:262–274.
2014.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang J, Wang G, Gong L, Sun G, Shi B, Bao
H and Duan Y: Isopsoralen regulates PPAR-γ/WNT to inhibit oxidative
stress in osteoporosis. Mol Med Rep. 17:1125–1131. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Wan Y, Chong LW and Evans RM: PPAR-gamma
regulates osteoclastogenesis in mice. Nat Med. 13:1496–1503.
2007.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Rossi A, Kapahi P, Natoli G, Takahashi T,
Chen Y, Karin M and Santoro MG: Anti-inflammatory cyclopentenone
prostaglandins are direct inhibitors of IkappaB kinase. Nature.
403:103–108. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Zhang M, Qian C, Zheng ZG, Qian F, Wang Y,
Thu PM, Zhang X, Zhou Y, Tu L, Liu Q, et al: Jujuboside A promotes
Aβ clearance and ameliorates cognitive deficiency in Alzheimer's
disease through activating Axl/HSP90/PPARγ pathway. Theranostics.
8:4262–4278. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Hu Y, Bobb D, He J, Hill DA and Dome JS:
The HSP90 inhibitor alvespimycin enhances the potency of telomerase
inhibition by imetelstat in human osteosarcoma. Cancer Biol Ther.
16:949–957. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Mellatyar H, Talaei S,
Pilehvar-Soltanahmadi Y, Barzegar A, Akbarzadeh A, Shahabi A,
Barekati-Mowahed M and Zarghami N: Targeted cancer therapy through
17-DMAG as an Hsp90 inhibitor: Overview and current state of the
art. Biomed Pharmacother. 102:608–617. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tsai YC, Leu SY, Chen SY, Kung CW, Lee YM,
Liu YP, Yen MH and Cheng PY: 17-DMAG, an Hsp90 inhibitor,
ameliorates ovariectomy-induced obesity in rats. Life Sci.
232(116672)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hertlein E, Wagner AJ, Jones J, Lin TS,
Maddocks KJ, Towns WH III, Goettl VM, Zhang X, Jarjoura D, Raymond
CA, et al: 17-DMAG targets the nuclear factor-kappaB family of
proteins to induce apoptosis in chronic lymphocytic leukemia:
Clinical implications of HSP90 inhibition. Blood. 116:45–53.
2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ge J, Normant E, Porter JR, Ali JA,
Dembski MS, Gao Y, Georges AT, Grenier L, Pak RH, Patterson J, et
al: Design, synthesis, and biological evaluation of hydroquinone
derivatives of 17-amino-17-demethoxygeldanamycin as potent,
water-soluble inhibitors of Hsp90. J Med Chem. 49:4606–4615.
2006.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Wu JS, Tsai HD, Cheung WM, Hsu CY and Lin
TN: PPAR-γ ameliorates neuronal apoptosis and ischemic brain injury
via suppressing NF-κB-driven p22phox transcription. Mol Neurobiol.
53:3626–3645. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Zininga T, Ramatsui L and Shonhai A: Heat
shock proteins as immunomodulants. Molecules.
23(2846)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kim HJ, Hwang NR and Lee KJ: Heat shock
responses for understanding diseases of protein denaturation. Mol
Cells. 23:123–131. 2007.PubMed/NCBI
|
|
18
|
Nguyen MT, Csermely P and Sőti C: Hsp90
chaperones PPARγ and regulates differentiation and survival of
3T3-L1 adipocytes. Cell Death Differ. 20:1654–1663. 2013.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Lee KJ, Ha ES, Kim MK, Lee SH, Suh JS, Lee
SH, Park KH, Park JH, Kim DJ, Kang D, et al: CD36 signaling
inhibits the translation of heat shock protein 70 induced by
oxidized low density lipoprotein through activation of peroxisome
proliferators-activated receptor gamma. Exp Mol Med. 40:658–668.
2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen TH, Shih CY, Hsu WL and Chou TC:
Mechanisms of nifedipine-downregulated CD40L/sCD40L signaling in
collagen stimulated human platelets. PLoS One.
10(0127054)2015.PubMed/NCBI View Article : Google Scholar
|
